1-7 of 7
Jack Taunton, PhD
Close
Sort by
Journal Articles

Protein Translocation Inhibitors Overcome Cytokine-Induced Glucocorticoid Resistance in T-Cell Acute Lymphoblastic Leukemia

Lauren K. Meyer, Cristina Delgado-Martin, PhD, Phillip P. Sharp, PhD, Dustin McMinn, PhD, Christopher J. Kirk, PhD, Jack Taunton, PhD, Michelle L. Hermiston, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 805.
https://doi.org/10.1182/blood-2019-127537
Published: 2019
Journal Articles

JAK/STAT Pathway Inhibition Reverts IL7-Induced Glucocorticoid Resistance in a Subset of Human T-Cell Acute Lymphoblastic Leukemia

Cristina Delgado-Martin, PhD, Kristin Shimano, MD, Matthew S Zinter, MD, Justin T. Wahlstrom, MD, Geoffrey A. Smith, Jack Taunton, PhD, Stuart S. Winter, MD, Justine E. Roderick, PhD, Michelle Kelliher, PhD, Terzah M. Horton, MD PhD, Brent L. Wood, MD PhD, David T Teachey, MD, Michelle L. Hermiston, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3963.
https://doi.org/10.1182/blood.V128.22.3963.3963
Published: 2016
Journal Articles

Tofacitinib Reverses Growth Promoting Effects of the Bone Marrow Stromal Environment Though Inhibition of JAK1/STAT3 Signaling in Multiple Myeloma

Christine Lam, Megan Murnane, M.Sc., Geoffrey A. Smith, Jack Taunton, PhD, Blake T. Aftab, PhD, Arun P. Wiita, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2098.
https://doi.org/10.1182/blood.V128.22.2098.2098
Published: 2016
Journal Articles

Blocking Protein Secretion and Degradation Is a Novel Treatment Strategy For Malignant Cells With High Protein Load

Eric Lowe, Rebecca Maglathlin, Alana Lerner, Ph.D, Jack Taunton, PhD, Christopher J. Kirk, Ph.D, Shirin Arastu-Kapur, Ph.D
Journal: Blood
Blood (2013) 122 (21): 4439.
https://doi.org/10.1182/blood.V122.21.4439.4439
Published: 2013
Journal Articles

p90RSK2 Is Essential for FLT3-ITD-, but Dispensable for BCR-ABL-Induced Myeloid Leukemia

Shannon Elf, Tae-Wook Chung, PhD, Dean P. Blevins, Ifor Williams, MD, PhD, H. Jean Khoury, MD, Jack Taunton, PhD, Sumin Kang, PhD
Journal: Blood
Blood (2010) 116 (21): 1716.
https://doi.org/10.1182/blood.V116.21.1716.1716
Published: 2010
Journal Articles

p90RSK2 as a Therapeutic Target in Treatment of FGFR3-Expressing t(4;14) Multiple Myeloma.

Sumin Kang, PhD, Shaozhong Dong, PhD, Tinglei Gu, PhD, Ailan Guo, PhD, Michael S. Cohen, PhD, Sagar Lonial, MD, PhD, Petet Leif Bergsagel, MD, PhD, Jack Taunton, PhD, Roberto D. Polakiewicz, PhD, Jing Chen, PhD
Journal: Blood
Blood (2007) 110 (11): 253.
https://doi.org/10.1182/blood.V110.11.253.253
Published: 2007
Journal Articles

FGFR3 Activates RSK2 To Mediate Hematopoietic Transformation through Both Tyrosine Phosphorylation of RSK2 and Activation of the MEK/ERK Pathway.

Sumin Kang, PhD, Shaozhong Dong, PhD, Ting-lei Gu, PhD, Michael S. Cohen, Sagar Lonial, MD, H. Jean Khoury, PhD, D. Gary Gilliland, MD, PhD, Jack Taunton, PhD, Roberto D. Polakiewicz, PhD, Jing Chen, PhD
Journal: Blood
Blood (2006) 108 (11): 514.
https://doi.org/10.1182/blood.V108.11.514.514
Published: 2006